Targeting Death Receptors to Fight Cancer: From Biological Rational to Clinical Implementation

Publisher： Bentham Science Publishers

E-ISSN： 1875-533x|17|25|2713-2728

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.17, Iss.25, 2010-09, pp. : 2713-2728

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Editorial (Thematic Issue: Targeting Cell Death and Proliferation Receptors in Cancer)

By  

Current Pharmaceutical Design, Vol. 20, Iss. 17, 2014-05 ,pp. : 2797-2798

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting HER Receptors in Cancer

By  

Current Pharmaceutical Design, Vol. 19, Iss. 5, 2013-02 ,pp. : 808-817

Bentham Science Publishers

Access to resources Recommend Favorite

Death Receptors as Targets of Cancer Therapeutics

By  

Current Cancer Drug Targets, Vol. 4, Iss. 1, 2004-02 ,pp. : 97-104

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting of Peptide Cytotoxins to LHRH Receptors For Treatment of Cancer

By  

Current Drug Targets, Vol. 17, Iss. 5, 2016-04 ,pp. : 488-494

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting sphingolipid metabolism in head and neck cancer: rational therapeutic potentials

By Beckham Thomas H   Elojeimy Saeed   Cheng Joseph C   Turner Lorianne S   Hoffman Stanley R   Norris James S   Liu Xiang  

Expert Opinion on Therapeutic Targets, Vol. 14, Iss. 5, 2010-05 ,pp. : 529-539

Informa Healthcare

Access to resources Recommend Favorite